Correlation Between INMED PHARMACEUTICALS and Apple

Can any of the company-specific risk be diversified away by investing in both INMED PHARMACEUTICALS and Apple at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INMED PHARMACEUTICALS and Apple into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between INMED PHARMACEUTICALS INC and Apple Inc, you can compare the effects of market volatilities on INMED PHARMACEUTICALS and Apple and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INMED PHARMACEUTICALS with a short position of Apple. Check out your portfolio center. Please also check ongoing floating volatility patterns of INMED PHARMACEUTICALS and Apple.

Diversification Opportunities for INMED PHARMACEUTICALS and Apple

0.4

Correlation Coefficient

INMED PHARMACEUTICALS  Apple

Very weak diversification

The 3 months correlation between INMED and Apple is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding INMED PHARMACEUTICALS INC and Apple Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apple Inc and INMED PHARMACEUTICALS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INMED PHARMACEUTICALS INC are associated (or correlated) with Apple. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apple Inc has no effect on the direction of INMED PHARMACEUTICALS i.e., INMED PHARMACEUTICALS and Apple go up and down completely randomly.

Pair Corralation between INMED PHARMACEUTICALS and Apple

Assuming the 90 days trading horizon INMED PHARMACEUTICALS INC is expected to generate 12.04 times more return on investment than Apple. However, INMED PHARMACEUTICALS is 12.04 times more volatile than Apple Inc. It trades about 0.02 of its potential returns per unit of risk. Apple Inc is currently generating about 0.11 per unit of risk. If you would invest  3,590  in INMED PHARMACEUTICALS INC on September 26, 2024 and sell it today you would lose (3,196) from holding INMED PHARMACEUTICALS INC or give up 89.03% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	99.8%
Values	Daily Returns

INMED PHARMACEUTICALS INC  vs.  Apple Inc

INMED PHARMACEUTICALS INC

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in INMED PHARMACEUTICALS INC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain technical and fundamental indicators, INMED PHARMACEUTICALS reported solid returns over the last few months and may actually be approaching a breakup point.

Apple Inc

Risk-Adjusted Performance

21 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Apple Inc are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile fundamental indicators, Apple displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with INMED PHARMACEUTICALS and Apple

The main advantage of trading using opposite INMED PHARMACEUTICALS and Apple positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INMED PHARMACEUTICALS position performs unexpectedly, Apple can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apple will offset losses from the drop in Apple's long position.

The idea behind INMED PHARMACEUTICALS INC and Apple Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.